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Abstract
Background: The comorbidity of borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD) is
frequent, yet not well understood. The influence of childhood sexual abuse (CSA) in the development of this
comorbidity has been a focus of prior clinical studies, but empirical evidence to generalize this focus to the broader
population is lacking. Primary aims of the present study included evaluation of: (a) the association of this comorbidity
with decrements in health-related quality of life (HRQOL) and (b) the importance of CSA as a predictive factor for this
comorbidity in a general population sample.
Methods: We utilized data from Wave 2 of the National Epidemiological Survey on Alcohol and Related Conditions, a
nationally representative face-to-face survey evaluating mental health in the non-institutionalized adult population of
the United States. Data from respondents who met criteria for BPD and/or PTSD were analyzed (N = 4104) to
assess potential associations between and among lifetime BPD-PTSD comorbidity, CSA, gender, healthcare
usage, and mental and physical HRQOL.
Results: Lifetime comorbidity of BPD and PTSD was associated with more dysfunction than either individual
disorder; and the factors of gender, age, and CSA exhibited significant effects in the prediction of this comorbidity and
associated decrements in HRQOL.
Conclusions: Results support the measured focus on CSA as an important, but not necessary, etiologic factor and
emphasize this comorbidity as a source of greater suffering and public health burden than either BPD or PTSD alone.
The differential impact of these disorders occurring alone versus in comorbid form highlights the importance of
diagnosing both BPD and PTSD and attending to lifetime comorbidity.
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Borderline personality disorder (BPD) and posttraumatic
stress disorder (PTSD) co-occur in ways that are not yet
well understood, especially outside of clinical samples.
Fundamental questions remain, for example, regarding
whether these disorders share common underlying
factors, whether one disorder predisposes the other
and, more fundamentally, whether BPD and PTSD
are two independent disorders or variants of a single
syndrome on a spectrum of trauma-related pathology
(see, e.g., [1]).
BPD-PTSD comorbidity rates vary across studies,
likely reflecting differences in implementation of diag-
nostic criteria, methods of sampling and assessment, and
management of extraneous variables (e.g., demographics
and other comorbidities). Studies employing treatment-
seeking clinical samples report rates of PTSD among in-
dividuals with BPD ranging from 25 to 58 %, and rates
of BPD among individuals with PTSD ranging from 10
to 76 % (see [2]). Recent community-based, epidemio-
logical studies report prevalence rates of comorbid
PTSD among those meeting diagnostic criteria for BPD
ranging from 30 to 50 % (e.g., [2–4]), though some re-
port lower numbers (e.g., 17 % [5]); and rates of comor-
bid BPD among those with PTSD ranging from 6.6 to
24 % [2, 5–7]. Additionally, odds ratios for the associ-
ation between BPD and PTSD reflect high comorbidity,
with BPD groups having 7–10 times the odds of co-
occurring PTSD [3, 8].
Comparing BPD and PTSD
As defined by the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV-TR [9] and its recent revi-
sion, DSM-5 [10]), BPD and PTSD appear quite differ-
ent, save for the similarity that both may include
dissociative symptoms. Recently, Frías and Palma [1]
summarized the overlap in psychopathological mecha-
nisms of BPD and PTSD by referencing empirical sup-
port for the characterization that both disorders exhibit
more dissociative symptoms than (a) healthy controls
and/or (b) other mental disorders. Despite what seems
to be a narrow phenomenological overlap between BPD
and PTSD, the clinical presentation of these two disor-
ders can be easily confused [11, 12]. Furthermore, influ-
ential authors on the topic, Herman and van der Kolk
[13], described apparent similarities of disturbance
across BPD and PTSD in the core domains of affect
regulation, impulse control, reality testing, interpersonal
relationships, and self-integration.
Related to the question of similarity among BPD
and PTSD symptoms, the question of potential inter-
action of symptoms across these disorders also eludes
a simple answer. Evidence from a variety of clinical
studies supports the conceptualization of BPD and
PTSD as distinct clinical syndromes that exhibit
relatively independent constellations of symptoms
(e.g., [14–16]). Findings from other clinical studies,
however, suggest that the impact of this comorbidity
may include exacerbation of core symptoms of these
two disorders. Particularly, whereas some findings suggest
lesser or similar levels of emotion dysregulation-related
symptoms among individuals with this comorbidity ver-
sus BPD only [17, 18], other findings suggest that co-
morbid PTSD may play an exacerbating role in the
expression of affective instability [19, 20], and on the
lethality, intent, and triggers for intentional self-injury
[21] in BPD.
Etiology and the potential role of childhood sexual abuse
Common etiologic factors may play a role in the co-
occurrence of these two disorders. For decades, discus-
sion of etiological overlap between BPD and PTSD has
focused on childhood trauma, and particularly, child-
hood sexual abuse (CSA). Clearly, CSA can fulfill the re-
quired traumatic event criterion for diagnosis of PTSD
(e.g., ‘Criterion A’ of the DSM-IV and DSM-5 [9, 10]). With
regard to BPD, multidimensional theories recognize CSA
as a significant psychological risk factor (e.g., [11, 22, 23]).
Numerous studies report higher rates of CSA in BPD
patient samples than in other, ‘near-neighbor’ diagnosis
samples (e.g., [24–29]). Moreover, examination of the
differential predictive relationships of childhood phys-
ical and sexual abuse with later BPD diagnosis suggests
that CSA may be uniquely associated with BPD (e.g.,
[22, 30, 31]). The extent to which CSA interacts with
other risk factors for BPD may contribute to this CSA-
BPD association. For example, CSA may interact with
pathological family environment—with disrupted family
dynamics in cases of incest, or with family neglect in cases
of extra-familial CSA—and may be one of the clearest ex-
amples of the extreme invalidation theorized to be a key
early-life factor in the development of BPD [22].
Referencing the high prevalence of childhood trauma,
particularly CSA, in BPD samples, as well as anecdotal
clinical experience, some suggest that BPD is a chronic
variant of PTSD (e.g., [13, 32]). However, findings, such
as those of Zanarini et al. [33], in which substantially less
than 100 % of a high-severity, inpatient BPD sample re-
ported lifetime history of PTSD, argue against this
conceptualization. Rather, such findings support the
diathesis-stress and multifactorial models of BPD eti-
ology, in which different combinations and proportions
of inborn temperamental vulnerability and life experi-
ences result in BPD. As many researchers investigating
childhood abuse in BPD samples note, the role of CSA
in the pathogenesis of BPD, though important, is nei-
ther specific nor sufficient for the development of BPD
(e.g., [23, 34–38]).
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Clinical and public health outcomes
The comorbidity of BPD and PTSD may be an important
factor in clinical course, treatment response, and health-
related quality of life in BPD and PTSD samples. The as-
sociation of this comorbidity with particular difficulties for
affected individuals, treatment providers, and society (e.g.,
public health burden) and the body of evidence suggesting
that this comorbidity may affect expression of core fea-
tures of these disorders, together, underscore the need to
consider this comorbidity in research, treatment, and pol-
icy decisions. Better understanding of this comorbidity
could lead to more specific and promising treatment ap-
proaches [39]. Recent development of the first fully inte-
grated, concurrent, and empirically supported treatment
for comorbid BPD and PTSD by Harned and colleagues
[40, 41] reflects progress in this direction.
Few studies have examined BPD-PTSD comorbidity in
the general population. One such study by Connor et al.
[42] contributed preliminary support for the association
of greater burden of distress and dysfunction with this
comorbidity in the general population, but suffered lim-
ited generalizability due to its regionally bound sample,
very small comorbid group, lack of BPD-only group, and
use of posttraumatic stress symptoms (PTSS) rather than
full PTSD. Pagura et al. [2] presented the first examin-
ation of BPD-PTSD comorbidity in a large, nationally
representative sample: Data from Wave 2 of the Na-
tional Epidemiological Survey on Alcohol and Related
Conditions (NESARC [43]) were used to examine differ-
ences in psychopathology, childhood traumatic events,
and health-related quality of life (HRQOL) across indi-
viduals with BPD, PTSD, and comorbid BPD-PTSD. Re-
sults suggested that individuals with the comorbid
diagnosis had poorer HRQOL, more Axis I comorbidity,
increased odds of lifetime suicide attempt, and higher
prevalence of repeated traumatic events in childhood
than individuals with either diagnosis alone [2]. Individ-
uals with the comorbidity had significantly lower mental
HRQOL scores than those with BPD-only or PTSD-
only; and individuals with PTSD-only and those with the
comorbidity had significantly lower physical HRQOL
scores than those with BPD-only [2]. Additionally, exam-
ining what Pagura et al. refer to as symptom severity,
those in the comorbid group endorsed significantly more
BPD and PTSD symptom items than those in the BPD-
only and PTSD-only groups.
In their assessment of PD diagnoses, however,
Pagura et al. [2] employed diagnostic rules that do
not reflect the current consensus among PD re-
searchers and clinicians [44]. Most widely accepted
PD diagnosis guidelines (e.g., [10]) stipulate that each
criterion causes significant distress and/or impairment
in order to count toward the diagnosis. The guidelines
used by Pagura et al. only required distress and/or
impairment associated with one of the requisite cri-
teria in order to achieve the diagnosis, resulting in
potential over-diagnosis and prevalence rates that
were considerably higher than those seen in other
community studies [44].
Present study
The present study aimed to further examine BPD-
PTSDcomorbidity in a large, representative commu-
nity sample, utilizing data from Wave 2 of the Na-
tional Epidemiological Survey on Alcohol and
Related Conditions (NESARC [43]) to assess poten-
tial associations between and among BPD-PTSD co-
morbidity, CSA, gender, healthcare usage, and
mental and physical health-related quality of life
(HRQOL). Diverging from the prior NESARC-based
study by Pagura et al. [2], the present study
employed Trull et al.’s [44] re-analysis of the
NESARC PD data, which, in line with the predomin-
ant view on PD diagnosis, required that each criter-
ion be associated with distress/impairment in order
to count toward the diagnosis. Additionally, the
present study examined predictive factors and pat-
terns of healthcare usage across the BPD-only,
PTSD-only, and comorbid groups; focused on the
prevalence of a broad array of traumatic events
across the diagnostic groups; investigated the contri-
bution of CSA, itself, to variance in HRQOL; used
lifetime, rather than past-year, diagnosis of PTSD to
examine effects of lifetime comorbidity on public
health-related outcomes; and statistically examined
the distinction between the additive and synergistic
effects of BPD and PTSD on these public health-
related outcomes.
We hypothesized that: (1) CSA would be more
prevalent among both men and women with the co-
morbidity than among those with one of the two
diagnoses; and among men and women with BPD-
PTSD comorbidity, CSA would be among the most
prevalent types of traumatic experience. (2) Positive
history of CSA would be associated with greater odds
of meeting diagnostic criteria for BPD-PTSD comor-
bidity than meeting diagnostic criteria for either
PTSD or BPD alone. (3) There may be a gender dif-
ference in the association of BPD with PTSD. Specif-
ically, the odds ratios for prediction of BPD-PTSD
comorbidity may be different for women and men; (4)
BPD-PTSD comorbidity would be associated with
worse mental and physical HRQOL and with greater
and more intensive use of health care services than
BPD or PTSD alone. And (5) CSA would be associ-
ated with worse mental and physical HRQOL, but
this association would not be as robust as that with
BPD-PTSD comorbidity.
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Method
The National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC) was a nationally repre-
sentative face-to-face survey evaluating mental health
in the non-institutionalized adult (age 18 and over)
population of the United States. NESARC psychiatric
diagnoses were assessed by trained lay interviewers
using a fully structured interview. Wave 2, which in-
cluded both BPD and PTSD assessments, was con-
ducted in 2004-2005 with a sample of 34,653
completed interviews [43]. Oversampling of African-
Americans, Latinos, and young adults (ages 18-24)
was implemented. The data were weighted according
to this oversampling and to reflect design characteris-
tics of the survey. Adjustments were made for nonre-
sponse across sociodemographic characteristics; and
the weighted Wave 2 data were then adjusted, based
on the 2000 Decennial Census, to represent the civil-
ian population on sociodemographic variables includ-
ing region, age, race, and gender [3].
Measures
DSM-IV diagnoses
BPD was assessed on a lifetime basis using the Alcohol
Use Disorder and Associated Disabilities Interview Sche-
dule—DSM-IV Version (AUDADIS-IV [45]). PTSD was
assessed with regard to past-year and prior-to-past-year
diagnoses, also using the AUDADIS-IV. The AUDADIS-
IV is a fully structured diagnostic interview designed to
assess alcohol, drug, and other mental disorders in both
general and clinical populations according to DSM-IV cri-
teria [45]. The AUDADIS-IV requires that personality dis-
order symptoms should occur “most of the time
throughout your life, regardless of the situation and who
you were with.” Using a subsample of 1899 respondents,
fair to good test-retest and inter-rater reliability have been
demonstrated for Wave 2 Axis I and II AUDADIS-IV
diagnoses [46, 47]. Kappas indicated fair to good agree-
ment: For PTSD past-year and lifetime diagnoses, kappas
were 0.77 and 0.64, respectively; and for BPD, 0.71. In-
ternal consistency of symptom scales associated with BPD
and PTSD fell within the good range (alpha = 0.75–0.89);
and reliability of risk factor measures fell in the good-
to-excellent range (intraclass correlations = 0.50–0.94;
alpha = 0.64–0.90), further indicating the usefulness of
the AUDADIS-IV diagnostic measures [47].
The AUDADIS-IV PTSD section began with an enu-
meration of 27 types of potentially traumatic events de-
signed to operationalize part 1 of DSM-IV Criterion A.
Respondents who endorsed more than one potentially
traumatic event were asked to indicate which one they
considered to be the “worst stressful event.” Respondents
were then asked whether they felt extremely frightened,
helpless, or horrified during the event (consistent with
part 2 of DSM-IV Criterion A), as well as whether they felt
that they or someone close to them might die, be seriously
injured, or disabled during the event. Subsequent items
assessed DSM-IV PTSD symptoms—criteria B through
D—and duration (of at least one month; criterion E) in
reference to the respondents’ indicated event. At least one
symptom within Criterion B (re-experiencing), at least
three within Criterion C (avoidance and numbing), and at
least two within Criterion D (hyperarousal), together with
fulfillment of the DSM-IV clinical significance criterion of
impairment or distress, were required for diagnosis of life-
time PTSD (see, e.g., [7]).
In the present study, lifetime diagnosis of PTSD was
used in all central analyses. However, to offer findings that
would be more comparable with past (e.g., [2, 14, 16]) and
future studies using current, or past-year, PTSD in
analyses of HRQOL and healthcare usage, we also re-
port supplementary analyses based on current PTSD
diagnosis below. With regard to diagnosis of BPD, the
present study employed Trull et al.’s [44] re-analysis
of the NESARC PD data, requiring that each criterion
be associated with distress/impairment in order to
count toward the diagnosis. This re-analysis signifi-
cantly reduces the PD prevalence rates, bringing them
much more into line with recent epidemiological
studies in the U.S. and Britain.
Childhood sexual abuse
History of childhood sexual abuse (CSA) was assessed
based on response to the NESARC interview item,
“Were you ever sexually assaulted, molested, or raped,
or did you ever experience unwanted sexual activity?”
along with the following item assessing age at onset. En-
dorsement of the former, together with an answer less
than 16 (years of age) on the latter, counted as positive
endorsement of CSA (see [2]).
Other traumatic experiences
Traumatic experiences, other than CSA, assessed in the
NESARC interview and utilized in the present study in-
clude those related to: military combat, peacekeeping, ci-
vilian experience of war, experience as a refugee, life-
threatening accident/illness, natural disaster, physical as-
sault/abuse, neglect, witnessing serious fights at home,
kidnapping/being held hostage, being stalked, being held
up with a weapon, experiences of terrorist attack, witnes-
sing severe injury/death, unexpected death of someone
close, and serious illness/injury/traumatic experience of
someone close.
Physical and mental HRQOL
The SF-12v2 Health Survey [48] was used to assess partic-
ipants’ physical and mental HRQOL. Eight scales, four
physical (General Health, Physical Functioning, Role
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Physical, and Bodily Pain) and four mental (Mental
Health, Social Functioning, Role Emotional, and Vitality),
comprise this 12-item short-form health survey. The SF-
12v2 (standard version) asks respondents to recall over
the last four weeks. For example, “During the past 4 weeks,
how much of the time has your physical health or emo-
tional problems interfered with your social activities like
visiting with friends, relatives, and so forth?” Scoring was
conducted based on the SF-12v2 user’s manual [49],
resulting in norm-based scores with a standardized range
(0 to 100) and mean (50).
Healthcare usage
NESARC interview items assessing number of overnight
hospitalizations, days spent in the hospital, and number
of times treated in a hospital emergency room in the last
12 months were used to examine aspects of general
healthcare usage.
Analyses
Data analyses were conducted in SAS/STAT® software,
version 9.2 (Copyright, SAS Institute, Inc., registered
trademark of SAS Institute, Inc., Cary, NC, USA), and
Mplus, and the Wave 2 stratification and weighting sys-
tems that were part of the NESARC’s complex survey de-
sign were employed in these analyses. In SAS 9.2, such
complex survey sample analyses required use of proce-
dures equipped specifically for incorporation of complex
sampling design (i.e., PROC SURVEYMEANS, PROC
SURVEYREG, PROC SURVEYFREQ). Due to the number
of analyses and large sample employed, the p-value of less




Results from descriptive analyses of diagnostic status and
sociodemographic characteristics are presented in Table 1.
A total of 3074 individuals met criteria for the PTSD-only
group, 483 met for the BPD-only group, and 547 for the
comorbid group, comprising the full subsample of
NESARC Wave 2 respondents (N = 4104) whose data
were examined in the present study. These numbers indi-
cate the following comorbidity rates: 53.11 % of those who
met criteria for BPD also met criteria for lifetime PTSD;
and 14.69 % of those who met for PTSD also met for
BPD. Results of the Wald chi-square tests for independ-
ence of the row and column variables in the two-way ta-
bles crossing the diagnostic group variable (BPD-only vs.
PTSD-only vs. Comorbid BPD-PTSD) with each of the
sociodemographic variables (age group, gender, U.S. region,
marital status, education level, household income, and
race/ethnicity) indicated that the groups differed in terms
of age (χ2[6, n = 4104] = 122.21, Wald F*[6, 3687] = 20.34,
p < .0001), gender (χ2[2, n = 4104] = 47.47, Wald F*[2,
3691] = 23.73, p < .0001), marital status (χ2[4, n = 4104] =
45.83, Wald F*[4, 3689] = 11.45, p < .0001), and household
income (χ2[6, n = 4104] = 35.84, Wald F*[6, 3687] = 5.97,
p < .0001).
Looking at the descriptive statistics presented in
Table 1, several patterns stand out: Women tended to be
overrepresented in the PTSD-only group and men in the
BPD-only group. The BPD-only and comorbid groups
tended to be overrepresented in the ‘never married’ cat-
egory, whereas PTSD-only was overrepresented in the
‘married or living with someone as if married’ category.
The PTSD-only group was overrepresented at the higher
levels of education (though the Wald’s Chi-square test
indicated that the overall group differences for education
level were not significantly different from chance) and
household income; whereas the comorbid group was
overrepresented at the lowest levels of these. In terms
of race/ethnicity, PTSD-only was slightly underrepre-
sented and the comorbidity was overrepresented in the
American Indian group. Nearly the opposite was true
for the Asian group, in which PTSD-only was overrep-
resented and the comorbidity was underrepresented. In
the Hispanic group, the comorbidity was slightly over-
represented as compared to the two single-disorder
diagnoses.
CSA and other trauma prevalence rates
Calculation of the prevalence rates of different traumatic
experiences across the diagnostic groups and genders
(Table 2) supported the hypothesis that CSA would be
more prevalent among women and men with the comor-
bidity than those with either individual disorder, and that
CSA would be one of the most prevalent trauma types
among women and men with the comorbidity.
Approximately 36 % (196 of 547) of those in the co-
morbid group, 18.43 % (89 of 483) of those in the
BPD-only group, and 19.52 % (600 of 3074) of those
in the PTSD-only group reported CSA. Whereas the
CSA prevalence rate for women was slightly more
than double that for men in the comorbid group
(43.42 % vs. 19.14 %), this gender difference was
closer to 4-fold in the BPD-only (28.24 % vs. 7.62 %)
and PTSD-only (24.33 % vs. 6.51 %) groups. For both
women and men, the comorbid group had close to
double the CSA prevalence rate seen in either the
BPD-only or the PTSD-only group. A Wald’s Chi-
square test indicated that the difference in CSA
prevalence across the diagnostic groups was signifi-
cant (χ2[2, n = 4082] = 35.7594, Wald F*[2, 3669] =
17.87, p < .0001). Looking at the full range of trau-
matic experience prevalence rates, CSA was the 6th
most prevalent traumatic experience, out of 23 differ-
ent types of traumatic experiences, in the comorbid
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group. In the BPD-only group, CSA ranked 10th; and in
the PTSD-only group CSA ranked 9th most prevalent.
These analyses addressed all traumatic events reported,
and as such, were not limited to those events indicated
as the ‘worst stressful event.’
Predicting BPD-PTSD comorbidity: odds ratios based on
CSA, age, and gender
Results from the logistic regressions of diagnostic status
on CSA status, age group, and gender indicated that
these predictors had differential associations with
Table 1 Demographic characteristics of the sample
Characteristics PTSD-only BPD-only Comorbid
(n = 3074) (n = 483) (n = 547)
n (column %, row %) n (column %, row %) n (column %, row %)
Gender
Male 815 (26.5, 67.8) 224 (46.4, 18.7) 162 (29.6, 13.5)
Female 2259 (73.5, 77.8) 259 (53.6, 8.9) 385 (70.4, 13.3)
Age
20–29 381 (12.4, 63.2) 111 (23.0, 18.4) 111 (20.3, 18.4)
30–44 1007 (32.8, 72.0) 181 (37.5, 12.9) 211 (38.6, 15.1)
45–64 1246 (40.5, 77.6) 156 (32.3, 9.7) 203 (37.1, 12.6)
65+ 440 (14.3, 88.5) 35 (7.2, 7.0) 22 (4.0, 4.4)
Race/Ethnicity
African American 661 (21.5, 75.1) 98 (8.8, 11.4) 121 (22.1, 13.8)
American Indian/Alaskan 68 (2.2, 68.0) 11 (2.3, 11.0) 21 (3.8, 21.0)
Asian/Pacific Islander 66 (2.1, 84.6) 9 (1.9, 11.5) 3 (0.5, 3.9)
Caucasian 1774 (57.7, 75.4) 288 (59.6,12.2) 290 (53.0, 12.3)
Hispanic 505 (16.4, 72.8) 77 (15.9, 11.1) 112 (20.5, 16.1)
Education
< High school 538 (17.5, 74.0) 82 (17.0, 11.3) 107 (19.6, 14.7)
High school or equivalent 806 (26.2, 72.0) 156 (32.3, 13.9) 158 (28.9, 14.1)
Some college+ 1730 (56.3, 76.7) 245 (50.7, 10.9) 282 (51.6, 12.5)
Marital status
Married/cohabiting 1483 (48.2, 78.6) 197 (40.8, 10.4) 206 (37.7, 10.9)
Widowed/separated/divorced 1049 (34.1, 74.6) 159 (32.9, 11.3) 199 (36.4, 14.1)
Never married 542 (17.6, 66.8) 127 (26.3, 15.7) 142 (26.0, 17.5)
Household income
$0–$19,999 890 (29.0, 70.7) 133 (27.5, 10.6) 236 (43.1, 18.7)
$20,000–$34,999 677 (22.0, 75.3) 106 (21.9, 11.8) 116 (21.2, 12.9)
$35,000–$59,999 681 (22.2, 73.8) 133 (27.5, 14.4) 109 (19.9, 11.8)
$60,000+ 826 (26.9, 80.7) 111 (23.0, 10.9) 86 (15.7, 8.4)
U.S. region
New England 134 (4.4, 74.9) 15 (3.1, 8.4) 30 (5.5, 16.8)
Mid Atlantic 414 (13.5, 74.6) 63 (13.0, 11.4) 78 (14.3, 14.1)
East North Central 419 (13.6, 73.6) 60 (12.4, 10.5) 90 (16.5, 15.8)
West North Central 173 (5.6, 80.1) 21 (4.3, 9.7) 22 (4.0, 10.2)
South Atlantic 643 (20.9, 75.8) 103 (21.3, 12.1) 102 (18.6, 12.0)
East South Central 212 (6.9, 75.7) 25 (5.2, 8.9) 43 (7.9, 15.4)
West South Central 294 (9.6, 72.8) 52 (10.8, 12.9) 58 (10.6, 14.4)
Mountain 230 (7.5, 75.2) 45 (9.3, 14.7) 31 (5.7, 10.1)
Pacific 555 (18.1, 74.3) 99 (20.5, 13.3) 93 (17.0, 12.4)
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diagnostic status, that some gender differences occurred
in the prediction, and that some predictors were operating
differently across the genders. Specifically, the hypothesis
that positive history of CSA would be associated with
greater odds of meeting diagnostic criteria for BPD-PTSD
comorbidity than meeting diagnostic criteria for either
PTSD or BPD alone was supported: Those who reported
history of CSA (vs. those who did not) had significantly
greater odds of being in the comorbid group than in ei-
ther the BPD-only (ORcomorbid v. BPD = 2.259, 99 % CI
[1.373, 3.717]) or the PTSD-only group (ORcomorbid v.
PTSD = 2.359, 99 % CI [1.681, 3.310]).
Results partially supported the hypothesis of gender
difference in the association of BPD with PTSD: Being a
woman significantly increased the odds of being in the
PTSD-only group as compared to the BPD-only group
(OR PTSD v. BPD = 2.549, 99 % CI [1.791, 3.628]) or the co-
morbid group (OR PTSD v. comorbid = 1.580, 99 % CI [1.124,
2.222]), and being a woman increased the odds of being in
the comorbid group as compared to the BPD-only group
(OR comorbid v. BPD = 1.613, 99 % CI [1.044, 2.493]). Con-
versely, being a man significantly increased the odds of be-
ing in the BPD-only group as compared to the comorbid
group (ORBPD v. comorbid = 1.613, 99 % CI [1.044, 2.493]),
significantly increased the odds of being in the BPD-only
group as compared to the PTSD-only group (ORBPD v.
PTSD = 2.549, 99 % CI [1.791, 3.628]), and significantly in-
creased the odds of being in the comorbid group as com-
pared to the PTSD-only group (OR comorbid v. PTSD = 1.580,
99 % CI [1.124, 2.222]). Conducting these logistic regres-
sions separately for women and men yielded a pattern of
odds ratios that was very similar across the genders, with
Table 2 Prevalence of different types of traumatic experience across the diagnostic groups
PTSD-only BPD-only Comorbid
(n = 3074) (n = 483) (n = 547)
n (% within dx group, prevalence
rank within dx group)
n (% within dx group, prevalence
rank within dx group)
n (% within dx group, prevalence
rank within dx group)
Childhood sexual abuse/assault (CSA) 600 (19.52 %, 9) 89 (18.43 %, 10) 196 (35.83 %, 6)
Adult sexual abuse/assault (ASA) 175 (5.69 %, 16) 17 (3.52 %, 15) 39 (7.13 %, 16)
Military combat 178 (5.79 %, 15) 12 (2.48 %, 17) 26 (4.75 %, 17)
Peacekeeping/relief work in war zone 58 (1.89 %, 21) 13 (2.69 %, 16) 11 (2.01 %, 19)
Civilian experience of war 92 (2.99 %, 18) 8 (1.66 %, 18) 15 (2.74 %, 18)
Refugee experience 59 (1.92 %, 20) 1 (0.21 %, 20) 8 (1.46 %, 20)
Serious/life-threatening accident 782 (25.44 %, 5) 151 (31.26 %, 3) 201 (36.75 %, 5)
Serious/life-threatening illness 834 (27.13 %, 3) 123 (25.47 %, 6) 187 (34.19 %, 8)
Natural disaster 686 (22.32 %, 7) 115 (23.81 %, 7) 150 (27.24 %, 10)
Physical attack/abuse by caregiver before
age 18
351 (11.42 %, 13) 57 (11.80 %, 12) 139 (25.41 %, 12)
Neglect by caregiver before
age 18
313 (10.18 %, 14) 55 (11.39 %, 13) 138 (25.23 %, 13)
Witnessed fights between caregivers before
age 18
787 (25.60 %, 4) 141 (29.19 %, 4) 224 (40.95 %, 3)
Intimate partner violence 683 (22.22 %, 8) 104 (21.53 %, 9) 223 (40.77 %, 4)
Physical attack by anyone else 467 (15.19 %, 11) 113 (23.40 %, 8) 166 (30.35 %, 9)
Kidnapped/held hostage/POW 104 (3.38 %, 17) 13 (2.69 %, 16) 45 (8.23 %, 15)
Stalked 585 (19.03 %, 10) 81 (16.77 %, 11) 142 (25.96 %, 11)
Mugged 700 (22.77 %, 6) 138 (28.57 %, 5) 192 (35.10 %, 7)
Death of someone close in a terrorist attack 58 (1.89 %, 21) 5 (1.04 %, 19) 8 (1.46 %, 20)
Injured in terrorist attack 7 (0.23 %, 22) 0 (0.0 %, 21) 1 (0.18 %, 22)
Direct experience of terrorist attack
(without injury)
63 (2.05 %, 19) 8 (1.66 %, 18) 5 (0.19 %, 21)
Saw someone badly injured/killed 1148 (37.35 %, 2) 164 (33.95 %, 2) 257 (46.98 %, 2)
Unexpected death of someone close 1937 (63.01 %, 1) 269 (55.69 %, 1) 386 (70.57 %, 1)
Any other traumatic experience 358 (11.65 %, 12) 39 (8.07 %, 14) 100 (18.28 %, 14)
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two notable exceptions: (1) Among women, older age con-
ferred slightly greater odds of being in the comorbid
group than in the BPD-only group (ORcomorbid v. BPD =
1.236, 95 % CI [1.013, 1.509]); whereas in men, this older
age-comorbidity association was not indicated (OR comorbid
v. BPD = 1.005, 95 % CI [0.756, 1.335]). (2) For men with
CSA, the odds ratio for having the comorbid diagnosis ver-
sus PTSD-only was even greater (approximately 3-fold:
ORcomorbid v. PTSD = 3.176, 99 % CI [1.366, 7.383]) than that
for women with CSA (approximately 2-fold: ORcomorbid v.
PTSD = 2.207, 99 % CI [1.507, 3.231]). Additionally, with re-
gard to age as a predictor across the whole sample (i.e., not
separating men and women), those in the older age groups
(as compared to the younger age groups) had significantly
greater odds of being in the PTSD-only group than in the
comorbid group (ORPTSD v. comorbid = 1.493, 99 % CI [1.255,
1.776]) or in the BPD-only group (ORPTSD v. BPD = 1.664,
99 % CI [1.399, 1.979]).
Health-Related Quality of Life (HRQOL)
Main effects of diagnostic group
Results from the series of SAS SURVEYREG procedures
conducted to assess the variance in scores on each SF-
12v2 scale accounted for by diagnostic status (BPD-only,
PTSD-only, or comorbid), by gender, and by their inter-
action (reported in full in Table 3) supported the hypoth-
esis that BPD-PTSD comorbidity would be associated
with worse HRQOL than either disorder alone. The diag-
nostic group variable had a significant main effect (p < .01)
on each of the eight SF-12v2 scales when all three levels of
the diagnostic status variable (BPD-only, PTSD-only, and
comorbid) were included. When PTSD-only was con-
trasted against the comorbid group, the diagnostic
group variable had a significant main effect (p < .01)
on each of the SF-12v2 scales except for Physical
Functioning, for which the main effect of diagnostic
status was only marginally significant (p = .014). When
Table 3 Variance in SF-12v2 scores accounted for by diagnostic status and gender
3-Level Dx Status Models: Comorbid vs. PTSD-only vs. BPD-only 2-Level: Comorbid vs. PTSD-only 2-Level: Comorbid vs. BPD-only
Scale/Effect dfnum F p dfnum F p dfnum F p
General Health (dfdenom = 3690)
Dx status 2 11.32 <.0001 1 22.57 <.0001 1 11.56 .0007
Gender 1 1.39 .2378 1 1.04 .3090 1 0.31 .5797
Social Functioning (dfdenom = 3687)
Dx status 2 57.43 <.0001 1 97.42 <.0001 1 12.59 .0004
Gender 1 9.28 .0023 1 7.80 .0053 1 9.76 .0019
Dx status*Gender – – – 1 5.23 .0223 – – –
Role Emotional Functioning (dfdenom = 3689)
Dx status 2 56.04 <.0001 1 100.79 <.0001 1 19.52 <.0001
Gender 1 2.59 .1077 1 1.87 .1718 1 2.81 .0942
Mental Health (dfdenom = 3688)
Dx status 2 80.95 <.0001 1 119.53 <.0001 1 6.94 .0086
Gender 1 17.13 <.0001 1 16.30 <.0001 1 13.35 .0003
Dx status*Gender – – – 1 4.38 .0365 – – –
Physical Functioning (dfdenom = 3691)
Dx status 2 6.00 .0025 1 6.01 .0143 1 12.50 .0004
Gender 1 0.21 .6465 1 0.03 .8668 1 0.02 .8874
Role Physical Functioning (dfdenom = 3690)
Dx status 2 9.87 <.0001 1 18.87 <.0001 1 14.18 .0002
Gender 1 0.12 .7280 1 0.01 .9301 1 0.35 .5545
Vitality (dfdenom = 3688)
Dx status 2 19.57 <.0001 1 26.74 <.0001 1 1.16 .2821
Gender 1 18.50 <.0001 1 14.64 <.0001 1 15.52 <.0001
Bodily Pain (dfdenom = 3689)
Dx status 2 9.53 <.0001 1 18.37 <.0001 1 13.05 .0003
Gender 1 0.05 .8266 1 0.12 .7309 1 0.60 .4393
Results for interaction effects are listed only where p < .05; p-values less than .01 are bolded
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BPD-only was contrasted against the comorbid group,
the diagnostic group variable had a significant main
effect (p < .01) on each of the 8 SF-12v2 scales except
for Vitality. Mean SF-12v2 scale scores calculated for
each diagnostic group using the SAS SURVEYMEANS
procedure (Table 4) indicated that the main effect of
diagnostic group can be characterized as an associ-
ation between BPD-PTSD comorbidity and greater
deficits in HRQOL than those seen in PTSD or BPD
alone.
Main effects of gender
Across the 3-level (including all three levels of the
diagnostic status variable) and 2-level (using a two-
level diagnosis variable so as to contrast either BPD-
only or PTSD-only with the comorbidity) analyses, a
main effect of gender (p < .01) was seen on three
scales: Social Functioning, Mental Health, and Vital-
ity. Mean SF-12v2 scale scores for each gender
(Table 4) indicated that these main effects reflect
greater deficits for women than for men across all
three diagnostic groups in these areas of HRQOL.
Diagnostic group-by-gender interactions
In the analyses comparing PTSD-only with the
comorbidity, marginally significant diagnostic group-
by-gender interactions emerged on the Social Func-
tioning (p = .022) and Mental Health (p = .037) scales.
Mean scale scores (Table 4) indicated that the association
of lower functioning with the comorbidity (versus
PTSD-only) was greater for women than for men on
these two scales.
Effects of CSA on HRQOL
Results from the series of SAS SURVEYREG procedures
conducted to assess the variance in scores on each SF-
12v2 scale accounted for by CSA status, along with gen-
der, diagnostic status, and all 2- and 3-way interactions
(Table 5) supported the hypothesis that CSA would be as-
sociated with worse HRQOL than no CSA, but that these
associations would not be as robust as those between
diagnostic status and HRQOL. In analyses including just
the CSA status variable and gender as predictors, CSA
had a significant main effect (p < .01) on each of the eight
SF-12v2 scales, at least a marginally significant main effect
of gender (p < .05) emerged for all scales, and no signifi-
cant interactions between CSA and gender occurred.
Mean scale scores for the CSA vs. no-CSA groups indi-
cated that these main effects of CSA reflected an associ-
ation between history of CSA and lower HRQOL.
However, when CSA status was entered into the models
with diagnostic status (three levels: Comorbid, BPD-only,
and PTSD-only) and all 2- and 3-way interactions (among
diagnosis, CSA, and gender), the main effect of CSA no
longer emerged on any of the SF-12v2 scales; the diagnos-
tic group variable maintained a significant main effect
(p < .01) on all scales; and gender had a significant main
effect (p < .01) on Mental Health and Vitality.
Additive versus synergistic effects of BPD and PTSD
In order to assess whether the effects of BPD-PTSD co-
morbidity on HRQOL reflected additive effects of the
two disorders or the synergistic effect of their inter-
action, additional SAS SURVEYREG analyses were con-
ducted with BPD and PTSD as separate, dichotomous
variables. A marginally significant interaction of BPD
and PTSD emerged on the Vitality scale (p = .034). Be-
yond this interaction of interest, these analyses revealed
additional interactions: On the Mental Health scale, a
marginally significant PTSD-CSA interaction emerged
(p = .045); and three-way interactions among PTSD,
CSA, and gender emerged on Physical Functioning
(p = .007) and, though only marginally significant, on
Role Physical Functioning (p = .014). Four-way inter-
actions were pooled, in these analyses, after it was
determined that they were not significant. Addition-
ally, when the three-way interactions were pooled for
those scales that did not exhibit any significant three-way
interactions (i.e., those other than Physical Functioning
and Role Physical Functioning), significant BPD-PTSD in-
teractions occurred on the Mental Health and Vitality
scales1.
Healthcare usage
Results from the series of SAS SURVEYREG procedures
conducted to assess the variance in the healthcare usage
variables (number of overnight hospitalizations, days spent
in hospital, and number of times treated in a hospital
emergency room [ER] in the last 12 months) accounted
for by diagnostic status, gender, CSA status, and all 2- and
3-way interactions largely supported the hypothesis that
BPD-PTSD comorbidity would be associated with more
intensive use of healthcare services than either disorder
alone. Diagnostic status had a significant main effect on
times treated in ER, F(2, 3663) = 6.19, p < .01, and a mar-
ginally significant main effect on number of days spent in
hospital, F(2, 3664) = 3.07, p = .046. No other main effects,
nor any interactions, achieved significance. The means of
these two healthcare usage variables for the comorbid
group (Mdays = 2.752, SE = .563; MER = 1.188, SE = .132)
were greater than those for either of the single-disorder
groups (BPD-only: Mdays = 1.963, SE = .355; MER = .753,
SE = .089; PTSD-only: Mdays = 1.538, SE = .158; MER = .653,
SE = .035)2.
Additive versus synergistic effects of BPD and PTSD
When these SAS SURVEYREGs were run with BPD and
PTSD as separate variables, no significant interactions of
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Table 4 SF-12v2 Scale means by diagnostic group, by gender, and by diagnostic group*gender











(n = 3074, Moverall = 46.64) (n = 483, Moverall = 44.71) (n = 547, Moverall = 41.08)
M (SE) M (SE) M (SE) M (SE) M (SE) M (SE) M (SE) M (SE)
Men Women Men Women Men Women
(M = 46.75) (M = 46.60) (M = 45.29) (M = 44.11) (M = 42.32) (M = 40.43)
General health 46.16 (0.29) 45.00 (0.66) 41.21 (0.73) 44.40 (0.48) 45.90 (0.30) 45.01 (0.54) 46.65 (0.33) 44.55 (0.85) 45.47 (0.83) 40.96 (0.85) 41.33 (0.72)
Social funct. 46.85 (0.27) 42.63 (0.62) 38.31 (0.69) 45.66 (0.42) 45.06 (0.30) 47.14 (0.49) 46.73 (0.31) 43.65 (0.79) 41.57 (0.83) 41.00 (0.71) 36.92 (0.71)
Role emotional funct. 45.05 (0.27) 41.37 (0.57) 36.63 (0.64) 43.64 (0.43) 43.49 (0.29) 45.23 (0.50) 44.98 (0.32) 41.97 (0.78) 40.74 (0.75) 37.92 (0.79) 35.97 (0.58)
Mental health 46.67 (0.25) 41.10 (0.59) 37.71 (0.64) 45.75 (0.41) 44.41 (0.27) 47.73 (0.44) 46.22 (0.28) 42.21 (0.79) 39.95 (0.81) 40.83 (0.76) 36.09 (0.65)
Physical funct. 47.39 (0.27) 49.05 (0.63) 45.51 (0.65) 47.85 (0.43) 47.14 (0.28) 47.89 (0.52) 47.18 (0.31) 49.40 (0.69) 48.69 (0.96) 45.23 (0.74) 45.66 (0.57)
Role physical funct. 46.27 (0.25) 46.38 (0.61) 42.72 (0.60) 45.75 (0.40) 45.89 (0.26) 46.00 (0.49) 46.38 (0.28) 46.66 (0.80) 46.09 (0.86) 43.07 (0.69) 42.54 (0.59)
Vitality 48.56 (0.24) 46.02 (0.51) 44.38 (0.57) 48.80 (0.40) 47.19 (0.25) 49.59 (0.48) 48.13 (0.27) 47.23 (0.68) 44.76 (0.59) 47.11 (0.70) 42.97 (0.51)

















BPD and PTSD emerged, suggesting that the effects of
this comorbidity on these healthcare usage variables are
better characterized as additive, rather than synergistic3.
Discussion
Results of the present study supported many of the hy-
potheses. In particular, the finding that those who re-
ported history of CSA had significantly greater odds of
being in the comorbid group than either the BPD-only
or PTSD-only groups provides empirical, general
population-based support for the focus on CSA as an
important potential precursor to BPD-PTSD comorbid-
ity. Gender differences in the prediction of BPD-PTSD
comorbidity were not as straight-forward as hypothesi-
zed—being a woman did not increase the odds of being
in the comorbid group versus either of the single dis-
order groups. However, interesting gender difference
findings did emerge: Being a woman significantly in-
creased the odds of being in the PTSD-only group as
compared to the BPD-only group and as compared to
the comorbid group; and being a woman increased the
odds of being in the comorbid group as compared to the
BPD-only group. This pattern suggests the possibility
that gender difference in PTSD prevalence (which con-
trasts the relatively gender-balanced BPD prevalence)
may contribute to, if not drive, the gender difference in
the comorbidity. Looking at the prediction of diagnostic
status separately for women and men produced similar
patterns of prediction, save for two interesting discrep-
ancies: (1) The association between older age and the
comorbidity versus BPD-only was only significant for
women. Such a finding reiterates the need for examin-
ation of developmental factors to further elucidate this
comorbidity. (2) Among those with CSA, the odds of
having the comorbidity were significantly greater than
the odds of PTSD-only for both genders, but this differ-
ence was approximately 3-fold for men and 2-fold for
women. This finding suggests that CSA may be an even
more specific predictor of BPD-PTSD comorbidity
among men than among women.
Table 5 Variance in SF-12v2 scores accounted for by CSA and gender (Model 1), and by diagnostic status, CSA, and gender
(Model 2)
Model 1 Model 2
Scale/Effect dfnum F p Scale/Effect dfnum F p
General Health (dfdenom = 33914) General Health (dfdenom = 3668)
CSA 1 13.94 .0002 Dx status 2 10.55 <.0001
Gender 1 5.51 .0189 – – – –
Social Funct. (dfdenom = 33902) Social Functioning (dfdenom = 3665)
CSA 1 77.82 <.0001 Dx status 2 37.58 <.0001
Gender 1 5.48 .0193 – – – –
Role Emotional Funct. (dfdenom = 33902) Role Emotional Funct. (dfdenom = 3667)
CSA 1 58.18 <.0001 Dx status 2 42.63 <.0001
Gender 1 14.97 .0001 – – – –
Mental Health (dfdenom = 33898) Mental Health (dfdenom = 3666)
CSA 1 122.33 <.0001 Dx status 2 42.17 <.0001
Gender 1 16.43 <.0001 Gender 1 8.54 .0035
Physical Funct. (dfdenom = 33914) Physical Funct. (dfdenom = 3669)
CSA 1 12.16 .0005 Dx status 2 5.69 .0034
Gender 1 23.63 <.0001 – – – –
Role Physical Funct. (dfdenom = 33903) Role Physical Funct. (dfdenom = 3668)
CSA 1 16.04 <.0001 Dx status 2 11.15 <.0001
Gender 1 23.60 <.0001 – – – –
Vitality (dfdenom = 33901) Vitality (dfdenom = 3666)
CSA 1 43.85 <.0001 Dx status 2 19.65 <.0001
Gender 1 38.35 <.0001 Gender 1 7.99 .0047
Bodily Pain (dfdenom = 33902) Bodily Pain (dfdenom = 3667)
CSA 1 46.22 <.0001 Dx status 2 7.90 .0004
Gender 1 10.74 .0011 – – – –
Results are listed only for effects where p < .05; p-values less than .01 are bolded
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When age was examined as a predictive factor across
the entire sample (i.e., not separated by gender), those in
the older age groups had significantly greater odds of be-
ing in the PTSD-only group than in the comorbid or
BPD-only groups. Such a finding calls attention to the
need for further examination of BPD, PTSD, and their
comorbidity from a developmental lifespan perspective.
Is this age-related finding merely the result of the accu-
mulation of more years, and/or more vulnerable years,
in which to potentially experience trauma? Are we see-
ing the result of some people ‘aging out’ of their BPD
diagnoses? Researchers are now looking at the stability
of BPD diagnosis and changes in symptomatology later
in life, for example, examining the possibility that
changes related to personality later in life (e.g., less clin-
ically significant impulsivity) place some individuals who
once met criteria for BPD outside of the diagnosis and
into a subthreshold or qualitatively distinct category (for
a review of relevant findings, see Oltmanns & Balsis
[50]). Moreover, changing contexts in later life can alter
the impact of personality disorders (PDs) and/or individ-
ual symptoms, adding further complexity to the picture
of changes in PD pathology across the lifespan [50].
Examination of the prevalence of a broad array of po-
tentially traumatic experiences, from both childhood and
adulthood, in our sample offered some additional sup-
port for the notion of CSA an important part of the
trauma profile associated with BPD-PTSD comorbidity.
CSA ranked in the upper range of reported traumas (6th
out of 23 types of traumatic experience) in the comorbid
group, and some of those five types ranking higher than
CSA are arguably relatively inevitable by the time of
adulthood (e.g., the unexpected death of a close loved
one). Comparing prevalence rates across diagnostic
groups and gender was, perhaps, more instructive than
rank ordering. The comorbid group had more than
double the prevalence rate of CSA than that seen in ei-
ther of the single-disorder groups. And, lining up with
the suggestion made above that CSA may be a more
specific predictor of BPD-PTSD comorbidity for men
than for women, the percentage of comorbid men
(19.14 %) who reported CSA was greater than that of
BPD-only men (7.62 %) or PTSD-only men (6.51 %) who
reported CSA; and the difference for women across the
diagnostic groups was less pronounced (43.42, 28.24,
and 24.33 %, respectively). Accordingly, the gender dis-
parity in CSA prevalence rate was much smaller in the
comorbid group (19.14 % of men vs. 43.42 % of women)
than in either of the single-disorder groups (BPD-only:
7.62 % vs. 28.24 % and PTSD-only: 6.51 % vs. 24.33 %).
In addition to examining traumatic experiences and
potential predictive factors associated with BPD-PTSD
comorbidity, the present study examined associations
between this comorbidity and public health-related
dependent variables—specifically, health-related quality
of life (HRQOL) and usage of healthcare services. Re-
sults of the HRQOL analyses supported the hypothesis
that BPD-PTSD comorbidity would be associated with
particular deficits. An association was found between
BPD-PTSD comorbidity and lower HRQOL than seen in
BPD alone or PTSD alone, generally echoing the find-
ings of prior clinical (e.g., [15, 16]) and community (e.g.,
[2]) studies. Furthermore, our findings extend prior find-
ings to the context of lifetime comorbidity, suggesting
that deficits in HRQOL associated with BPD-PTSD co-
morbidity may not be limited to cases involving current
or past year diagnosis of PTSD.
Results of additional analyses representing the comor-
bidity as the interaction of BPD and PTSD indicated that
most of the associations of this comorbidity with lower
HRQOL reflect additive rather than synergistic effects of
BPD and PTSD. Some BPD-PTSD interactions, however,
did emerge. Depending on the specification of these
models (i.e., pooling or not pooling of non-significant
three-way interactions) and use of lifetime versus
current PTSD, either marginally or fully significant inter-
actions of BPD and PTSD emerged on the Vitality and
Mental Health scales. Thus, the possibility of synergistic
effects of BPD and PTSD on HRQOL should not be
ruled out of consideration, in particular with regard to
the Vitality and Mental Health subareas of HRQOL.
As hypothesized, childhood sexual abuse (CSA) also
showed an association with lower HRQOL, and this as-
sociation was not as robust as that between the comor-
bidity and lower HRQOL. CSA may, in fact, have a
lasting impact on the lives of individuals with BPD,
PTSD, or both; but the deficits in HRQOL associated
with BPD-PTSD comorbidity cannot be explained away
based on this, albeit impactful, childhood trauma. Gen-
der also exhibited significant main effects on many of
the HRQOL scales. Women tended to show significantly
lower HRQOL. Additionally, in the comparison of those
with PTSD-only versus BPD-PTSD comorbidity, margin-
ally significant interactions suggest that the association
between the comorbidity and deficits on the Social
Functioning and Mental Health scales may be stronger
for women than for men.
Echoing findings of previous clinical studies (e.g.,
[15, 16]), results of the present study suggest an associ-
ation between BPD-PTSD comorbidity and patterns of
greater healthcare usage, namely greater frequency of
treatment in a hospital ER and a trend toward more days
spent in the hospital. Our supplementary current PTSD
comorbidity analyses of healthcare usage also reflected the
association of this comorbidity with greater usage of ER
care, but not days spent in the hospital.
Given the overlap between analyses in the present study
and those reported by Pagura et al. [2]—using the same
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data, but differing in diagnostic and analytic approach—we
conducted an informal comparison of findings. Several dif-
ferences stand out, including differences in prevalence and
co-occurrence as well as differences in the pattern of
HRQOL results. As expected, with the use of more strin-
gent diagnostic rules for BPD in the present study, the
composition of the diagnostic groups changed fundamen-
tally. Whereas Pagura et al. found that 30.2 % of individuals
diagnosed with BPD were also diagnosed with PTSD, and
24.2 % of individuals diagnosed with PTSD were also diag-
nosed with BPD; the present study found that 53.11 % of
those who met criteria for BPD also met criteria for lifetime
PTSD, and 14.69 % of those who met for PTSD also met
for BPD.
In analyses addressing HRQOL, the present study’s find-
ings diverged from Pagura et al. [2] with regard to the pat-
tern of results for the physical, but not mental, SF-12v2
scales. In Pagura et al., individuals with PTSD-only and the
comorbidity had significantly lower physical scale scores
than those with BPD-only; but the comorbid diagnosis was
not associated with significantly lower scores than PTSD-
only on these scales. In the primary analyses of the present
study (i.e., using lifetime diagnosis of PTSD) and the major-
ity of the supplementary analyses (i.e., using current PTSD
diagnosis, to be more comparable with the analyses of
Pagura et al.), the comorbidity was associated with signifi-
cantly lower SF-12v2 scores than either single disorder
group on both the mental and physical scales. Additionally,
whereas the results of Pagura et al. indicated no significant
interactions between the comorbidity and gender (using a
less stringent p < .05 cutoff for significance) for HRQOL,
the present study found marginally significant (p < .05) in-
teractions suggestive of a more detrimental impact of life-
time BPD-PTSD comorbidity on the Social Functioning
and Mental Health scales for women than for men, when
contrasting the comorbidity against PTSD-only.
Additionally, a supplementary analysis was conducted in
the present study to replicate Pagura et al.’s [2] analysis
comparing BPD and PTSD symptom item counts across
the diagnostic groups. Though the difference we found be-
tween the comorbid and BPD-only groups was of a notably
smaller magnitude, our results do replicate the rank order-
ing of symptom item endorsement found by Pagura et al.,
such that the comorbid group, on average, endorsed more
BPD and PTSD symptom items than either single-disorder
group. Pagura et al. concluded that their finding indicated
an impact of BPD-PTSD comorbidity on central features of
each individual disorder—something not found in a num-
ber of prior studies (e.g., [15, 16])—and that this discrepant
finding arose from the differences between their large, com-
munity sample and the small, clinical samples used in prior
studies. Though the finding of the present study generally
supports this notion of the impact of this comorbidity on
core features of the disorders, further examination across
different types of samples, and with more thorough mea-
sures of symptom expression and severity, will be necessary
in order to firmly support such conclusions.
Limitations
Several methodological limitations in the present study
merit consideration. Reliance on retrospective self-
report, most notably in the report of trauma experiences,
as always, must be regarded with caution. Additionally,
some (e.g., [51]) criticize the NESARC for its use of PD
interview items that were not drawn directly from a
traditional, validated Axis II diagnostic instrument.
However, no single PD interview has been shown to be
superior to others; and these other interviews disagree
with each other at times [44]. Thus, although notable, it
is not clear whether this is a significant limitation.
Diverging from the pure epidemiological approach of
isolating disorders under investigation via statistical con-
trols (e.g., for sociodemographics and other comorbid
diagnoses), the present study conducted analyses with-
out additional statistical controls. There are myriad pros
and cons associated with controlling for such factors.
The present study adopted the stance that overly con-
trolling for other factors could reduce the meaning of re-
sults such as to represent patterns of disorder that are
rarely seen in real life (e.g., BPD-PTSD comorbidity with
no other Axis I or II disorder). Thus, rather than use
statistical controls, the present study examined sociode-
mographic variables via descriptive analyses and inte-
grated these variables, as appropriate, into central
analyses (e.g., inclusion of the age group and gender var-
iables in the logistic regressions and subsequent separ-
ation of the logistic regressions by gender).
The absence of analyses examining specific parameters of
childhood sexual abuse (CSA) reflects another important
limitation of the present study. A substantial body of find-
ings suggests that specific parameters of CSA (e.g., age at
onset, number of abusers/incidents, duration of abusive re-
lationship) may influence associations between CSA and
psychopathology; and findings relevant to BPD and PTSD,
in particular, highlight the potential predictive nature of
such parameters [15, 52]. Unfortunately, the NESARC data
provide little information relevant to such parameters of
CSA, specifying only age at onset of sexual abuse/assault,
frequency of sexual abuse/assault throughout the lifespan,
and age at most recent event of sexual abuse/assault. Con-
trary to expectations based on the literature and extant
findings, supplementary analyses conducted in the present
study to address whether age at onset and/or frequency of
abuse/assault were predictive of comorbid BPD+ PTSD
status indicated that these parameters were not significantly
predictive.
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Finally, the slightly high prevalence of lifetime PTSD
suggested by our results, and general concerns regarding
implementation of diagnostic criteria, prompted further
examination of PTSD prevalence and the NESARC diag-
nostic data for trauma and PTSD. The widely cited Na-
tional Comorbidity Survey [53] and its replication [54],
reported lifetime PTSD prevalence estimates of 7.8 and
6.8 %, respectively; but across varied epidemiologic stud-
ies, prevalence estimates range widely (i.e., from roughly
1 to 11 % [55]). Residing at the high end of this range,
our 9.48 % estimate may raise some questions regarding
the NESARC PTSD diagnosis. As described above, the
diagnostic interview employed in the NESARC closely
followed the DSM-IV criteria for diagnosis of PTSD. The
DSM-IV version of PTSD Criterion A allows for a rela-
tively broad range of potentially traumatic event types,
emphasizing the individual’s subjective experience of
these events in determination of whether a potentially
traumatic event has occurred (e.g., [56]). Supplementary
analysis of the ‘worst stressful events’ endorsed by the
PTSD-positive (PTSD+; n = 3621) individuals in the
present study indicated unexpected death of someone
close (882 individuals, 24.26 % of the PTSD+ individ-
uals), sexual abuse/assault (519, 14.33 %), and serious
life-threatening illness/accident/injury to someone close
to you (470, 12.98 %) as the three most prevalent. None
of the other event categories captured more than 6 %,
with beaten up by spouse/romantic partner ranking
fourth most prevalent and capturing 5.52 %. Of all event
types coded as a ‘most stressful life experiences’ in the
NESARC data, those designed to capture indirect
trauma are the most potentially concerning, as some of
these event categories—including the first and third
most prevalent in our PTSD+ sample—conceivably
could capture events that are not congruent with the
DSM-5 revision of Criterion A [10] or conventional ob-
jective notions of trauma. Both an unexpected death of
someone close and a serious, life-threatening illness/acci-
dent/injury of someone close are events that transpire
multiple times throughout most individuals’ lives.
Whereas the revised DSM-5 Criterion A specifies that
such indirect experiences of actual or threatened death
must be violent or accidental, DSM-IV (and thus
NESARC) did not make this specification, instead rely-
ing on respondents’ subjective reports of fear, helpless-
ness, or horror.
Conclusions
Overall, findings from the present study help to
generalize those from prior BPD-PTSD comorbidity
studies to the spectrum of pathology present in the gen-
eral U.S. population and to the context of lifetime co-
morbidity. Our findings reflect an important association
between CSA and this comorbidity in the general U.S.
population, offering support for the focus on this trauma
type as an important, but not necessary, etiologic factor.
With regard to public health-related outcomes associ-
ated with this comorbidity, deficits in HRQOL and in-
creased use of intensive healthcare services, as seen in
prior studies, emphasize this comorbidity as a source of
greater suffering and public health burden than either
BPD or PTSD alone. Further, our findings suggest that
the associations of this comorbidity with greater burden
of illness are not limited to cases of current or past-year
PTSD comorbidity. The present findings argue for the
consideration of lifetime comorbidity in clinical, re-
search, and policy-related decisions regarding the study
and treatment of these disorders. The differential impact
of these disorders occurring alone versus in comorbid
form highlights the importance of diagnosing both BPD
and PTSD and attending to lifetime comorbidity, despite
potential remission of PTSD symptoms. Thus, although
specific points of contrast emerged between our findings
and those of the prior NESARC-based study by Pagura et
al. [2], our overarching conclusions generally extend these
authors’ conclusions regarding the non-redundance of
BPD and PTSD and the particular burden of this comorbi-
dity—not only to the context of lifetime comorbidity, but
also according to the parameters of diagnostic groups de-
fined using a more conventional diagnostic algorithm for
BPD. Additionally, the present findings suggest several im-
portant future directions, including further investigation
of discrepant findings across different types of clinical and
community samples, longitudinal investigation of trajec-
tories of HRQOL during and after remission from full
PTSD among individuals with BPD, and further investiga-
tion of patterns of association across genders and age
groups.
Endnotes
1Repeating the HRQOL analyses using current ra-
ther than lifetime diagnosis of PTSD (i.e., the comorbid
and PTSD-only groups contained only individuals who
met criteria for current PTSD, and individuals with past
but not current PTSD were shifted to the BPD-only
group) yielded a very similar pattern of results. Supple-
mentary analyses assessing the additive versus synergistic
effects of BPD and current PTSD on HRQOL also
yielded results that were very similar to those reported
above. These results are available from the correspond-
ing author.
2Supplementary analyses employing current diagnosis
of PTSD highlighted times treated in ER as the only
dependent variable on which the diagnostic group variable
had a marginally significant (p = .0113) main effect. The
diagnostic group means again reflected higher usage of ER
treatment in the comorbid group (comorbid: MER = 1.283,
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SE = .156; BPD-only: MER = .750, SE = .078; PTSD-only:
MER = .720, SE = .048).
3Supplementary analyses employing current diagno-
sis of PTSD replicated this pattern of results: No signifi-
cant interactions of BPD and current PTSD emerged.
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